bioRxiv / medRxiv
open access
CC BY 4.0
Health-economic burden of chikungunya infection and potential cost-effectiveness of preventive vaccination in 31 countries
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.#454074
- Trial of an Inactivated Chikungunya Virus Vaccine#123551
- Detection of persistent viremia by a live attenuated vaccine strain of the chikungunya virus in a blood donor#1039004
- Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia#158040
- Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China#804536
Record · ID 419968
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive